2021
DOI: 10.1136/bcr-2021-242683
|View full text |Cite
|
Sign up to set email alerts
|

Febrile neutropenia due to COVID-19 in an immunocompetent patient

Abstract: While lymphopenia has been a common finding in COVID-19 infection, particularly in severe cases, febrile neutropenia has been very rarely reported in immunocompetent patients with COVID-19. Herein, we report the case of a 76-year-old hypertensive and diabetic man who was hospitalised with severe COVID-19 infection and developed delayed-onset severe neutropenia with neutropenic fever, which responded to treatment with antibiotics and granulocyte colony-stimulating factor. This case highlights the importance of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 7 publications
1
12
0
Order By: Relevance
“…This suggests that the course of IM might be associated with the percentage of immature neutrophils and that this percentage can be of prognostic significance. A similar trend was observed in COVID-19 patients, whereby, a dramatic increase in the number of immature neutrophils was observed in peripheral blood and immature neutrophil-to-VD2 T-cell ratio was an early marker for severe COVID-19 (61)(62)(63). What is even more interesting is that the percentage of rod nuclear neutrophils was positively correlated with copies of EBV DNA in blood.…”
Section: Discussionsupporting
confidence: 72%
“…This suggests that the course of IM might be associated with the percentage of immature neutrophils and that this percentage can be of prognostic significance. A similar trend was observed in COVID-19 patients, whereby, a dramatic increase in the number of immature neutrophils was observed in peripheral blood and immature neutrophil-to-VD2 T-cell ratio was an early marker for severe COVID-19 (61)(62)(63). What is even more interesting is that the percentage of rod nuclear neutrophils was positively correlated with copies of EBV DNA in blood.…”
Section: Discussionsupporting
confidence: 72%
“…Both the moderate (<1,000 cells/μl) and especially the severe neutropenia, which is also called agranulocytosis (<500 cells/μl), are conditions with an extraordinary risk of infections. The conditions require patient monitoring and empirical antibiotic therapy along with the administration of granulocyte colony-stimulating factor in some cases ( Devi et al., 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…12 13 On day 3, ANCs were>1200/µL, other routine laboratory investigations were also normal and the patient also improved clinically from COVID-19. Thus, it is learnt from this experience and available literature that an early or delayed severe neutropenia could be found during severe COVID-19 infection [2][3][4] and could be a result…”
Section: Discussionmentioning
confidence: 88%
“…The previous studies do not mention neutropenia as a manifestation of COVID-19 infection. There are only a few previous case reports on neutropenia in otherwise immunocompetent adult patients2–4 and an infant 5. The neutropenia in patients with COVID-19 with haematological malignancy6 7 or solid tumour8 has also been reported.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation